A Peptide Approach to Reducing alpha-Synuclein in Parkinson's Disease
Experimental Neurobiology
Iron-mediated interaction of alpha synuclein with lipid raft model membranes - Nanoscale (RSC Publishing)
Alpha Synuclein in Parkinson's Disease | StressMarq
Frontiers | The Role of Lipids in the Initiation of α-Synuclein Misfolding
Frontiers | Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson's Disease
3D Structure of Alpha-Synuclein Challenges Previous Parkinson's Theory
New Role for α-Synuclein: Stabilizing mRNA in P-Bodies | ALZFORUM
alpha-Synuclein-based Model for Studying Parkinsons Disease Pathology: R&D Systems
alpha-Synuclein Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
IJMS | Free Full-Text | The Role of α-Synuclein Oligomers in Parkinson's Disease
Frontiers | Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson's Disease
Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos - 2019 - Journal of Neurochemistry - Wiley Online Library
活性型 α-シヌクレイン・タンパク質 | アブカム
How does alpha-synuclein spread in Parkinson's? | by Lynn Duffy | Parkinson's UK | Medium
How is alpha‐synuclein cleared from the cell? - Stefanis - 2019 - Journal of Neurochemistry - Wiley Online Library
IJMS | Free Full-Text | Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease
The Cellular Environment Affects Monomeric α-Synuclein Structure: Trends in Biochemical Sciences
Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
Zeroing in on neurodegenerative α-synuclein | Nature Reviews Drug Discovery
Alpha Synuclein – The Science of Parkinson's
Modulating membrane binding of α-synuclein as a therapeutic strategy | PNAS
IJMS | Free Full-Text | The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses
α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide | eNeuro
Frontiers | Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3 | Science
